Dec. 2 at 7:05 PM
$ICU Zero adverse events in any study, ever.
The FDA has granted them 6 Breakthrough Device Designations, meaning 6 indications with fast track. Their device calms hyperinflammation and could have very broad application from Acute Kidney Infection to Sepsis to Cardio-renal disease to helping burn victims. Areva/military also studying. Received 2 grants and awards from National Kidney Foundation, other organizations. Will become standard of care right along antibiotics with cytokine storm cases, ARDS, severe Covid, etc.
Insane opportunity of a lifetime. Multi-billion dollar TAM, upwards of 10B-20B TAM.
Big players like Fresenius, Davita, Baxter, Stryker or McKesson may want to get involved with Distribution to all hospitals.
GL!
$MCK $DVA $BAX $SYK
